Related references
Note: Only part of the references are listed.Circulating tumor DNA in molecular assessment feasibly predicts early progression of pancreatic cancer that cannot be identified via initial imaging
Fumiaki Watanabe et al.
SCIENTIFIC REPORTS (2023)
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
Maria Victoria Garcia-Ortiz et al.
CLINICAL EPIGENETICS (2023)
Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations
Olga Partyka et al.
CANCERS (2023)
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
Lukas Vrba et al.
CLINICAL EPIGENETICS (2022)
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer
Sakti Chakrabarti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients
Brendan F. Miller et al.
SCIENTIFIC REPORTS (2021)
High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Shounak Majumder et al.
CLINICAL CANCER RESEARCH (2021)
Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer
Lee Ying et al.
PANCREAS (2021)
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Alison P. Klein
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
E. A. Klein et al.
ANNALS OF ONCOLOGY (2021)
Pancreatic Cancer: A Review
Wungki Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
Makoto Sugimori et al.
CANCER SCIENCE (2020)
Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients
Nidhi Singh et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
Winston Wong et al.
CANCER MANAGEMENT AND RESEARCH (2020)
SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis
Mehdi Manoochehri et al.
MOLECULAR ONCOLOGY (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer
Feng Cao et al.
CLINICAL EPIGENETICS (2020)
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
Marta Toledano-Fonseca et al.
CANCERS (2020)
Epigenetic inactivation ofIRX4is responsible for acceleration of cell growth in human pancreatic cancer
Kanchan Chakma et al.
CANCER SCIENCE (2020)
A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer
Keiko Shinjo et al.
PLOS ONE (2020)
Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic Cancer
Shengyue Li et al.
FRONTIERS IN GENETICS (2020)
Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
Jedrzej J. Jaworski et al.
CANCERS (2020)
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
Maria Cristina Curia et al.
BMC CANCER (2019)
Non-invasive detection of pancreatic cancer by measuring DNA methylation of Basonuclin 1 and Septin 9 in plasma
Xiao-Bin Li et al.
CHINESE MEDICAL JOURNAL (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
Maryam A. L. Eissa et al.
CLINICAL EPIGENETICS (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer
Sumitra Mohan et al.
SCIENTIFIC REPORTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Vincent Bernard et al.
GASTROENTEROLOGY (2019)
Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients
Huiming Chen et al.
AGING-US (2019)
Analysis of genome-wide in cell free DNA methylation: progress and prospect
Zhiyu Liu et al.
ANALYST (2019)
An update on treatment options for pancreatic adenocarcinoma
Aurelien Lambert et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
Min Kyeong Kim et al.
CLINICAL CHEMISTRY (2018)
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
Abderrahim Oussalah et al.
EBIOMEDICINE (2018)
Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer
S. Kruger et al.
ANNALS OF ONCOLOGY (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Pancreatic cancer circulating tumor cells: applications for personalized oncology
Benjamin J. DiPardo et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Principles of DNA methylation and their implications for biology and medicine
Yuval Dor et al.
LANCET (2018)
Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging
Stine Dam Henriksen et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening
Lele Song et al.
EPIGENOMICS (2017)
Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma
Stine Dam Henriksen et al.
ONCOTARGET (2017)
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
Chun-Xiao Song et al.
CELL RESEARCH (2017)
SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis
Wolf Arif Mardin et al.
PANCREAS (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
Stine Dam Henriksen et al.
CLINICAL EPIGENETICS (2016)
Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study
Fiona M. Walter et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
John B. Kisiel et al.
CLINICAL CANCER RESEARCH (2015)
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A. Zill et al.
CANCER DISCOVERY (2015)
Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Lesions
Hae Woon Baek et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2015)
Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer
Joshua Melson et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Molecular pathology of pancreatic cancer
Yuriko Saiki et al.
PATHOLOGY INTERNATIONAL (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
KRAS: feeding pancreatic cancer proliferation
Kirsten L. Bryant et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis
Zhe Huang et al.
TUMOR BIOLOGY (2014)
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
Todd M. Bauer et al.
CANCER (2013)
Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Joo Mi Yi et al.
CLINICAL CANCER RESEARCH (2013)
Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
Valerie Taly et al.
CLINICAL CHEMISTRY (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
Yotaro Kudo et al.
CANCER SCIENCE (2012)
The Role of Quantitative NPTX2 Hypermethylation as a Novel Serum Diagnostic Marker in Pancreatic Cancer
Joo Kyung Park et al.
PANCREAS (2012)
PRELIMINARY STUDY ANALYZING THE METHYLATED GENES IN THE PLASMA OF PATIENTS WITH PANCREATIC CANCER
J. W. Park et al.
SCANDINAVIAN JOURNAL OF SURGERY (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
Seung-Gi Jin et al.
CANCER RESEARCH (2011)
The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma
Yi Zhu et al.
MEDICAL ONCOLOGY (2011)
Differential Methylation of Cell-Free Circulating DNA Among Patients With Pancreatic Cancer Versus Chronic Pancreatitis
Thomas Liggett et al.
CANCER (2010)
Methylation Profile of Circulating Plasma DNA in Patients With Pancreatic Cancer
Anatoliy A. Melnikov et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Mammalian DNA methyltransferases: A structural perspective
Xiaodong Cheng et al.
STRUCTURE (2008)
Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer
Joo Kyung Park et al.
PANCREAS (2007)
K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients - In relation to cigarette smoking
Li Jiao et al.
PANCREAS (2007)
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies
David S. Shames et al.
PLOS MEDICINE (2006)
Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma
Norihiro Sato et al.
CANCER (2006)
BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
Frank Diehl et al.
NATURE METHODS (2006)
CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials
NR Maisey et al.
BRITISH JOURNAL OF CANCER (2005)
Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling
N Sato et al.
CLINICAL CANCER RESEARCH (2005)
Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers
T Komazaki et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling
N Sato et al.
ONCOGENE (2004)
Aberrant methylation of preproenkephalin and p16 genes in pancreatic Intraepithelial neoplasia and pancreatic ductal adenocarcinoma
N Fukushima et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine
ED Saad et al.
JOURNAL OF GASTROINTESTINAL CANCER (2002)
Share Paper
